Therapeutic aspects of typhoidal salmonellosis in childhood: the Karachi experience

References

• Ivanoff B, Levine MM, Lambert PH. Vaccination against typhoid fever: present status. Bull WHO 1994; 72: 957–71.
   PubMed Web of Science ®Google Scholar
• Mathieu JJ, Henning KJ, Bell E, Frierden TR. Typhoid fever in New York city, 1980 through 1990. Arch Intern Med 1994; 154: 1713–18.
   PubMedGoogle Scholar
• Rowe B, Ward LR, Threlfall EJ. Spread of multiresistant typhoid fever. Lancet 1990; 336:1065.
   PubMed Web of Science ®Google Scholar
• Topley JM. Mild typhoid fever. Arch Dis Child 1986; 61: 164–7.
   PubMed Web of Science ®Google Scholar
• Ferrecio C, Levine MM, Manterola A, et al. Benign bacteremia caused by Salmonella typhi and paratyphi in children younger than 2 years. J Pediatr 1984; 104: 899–901.
   PubMed Web of Science ®Google Scholar
• Butler T, Islam A, Kabir I, Jones PK. Patterns of morbidity and mortality in typhoid fever dependent upon age and gender: Review of 552 hospitalized patients with diarrhea. Rev Infect Dis 1991; 13: 85–90.
   PubMedGoogle Scholar
• Gupta V, Gupta SK, Shukla VK, Gupta S. Perforated typhoid enteritis in children. Postgrad Med J 1994; 70: 19–22.
   PubMed Web of Science ®Google Scholar
• Bhutta ZA, Naqvi SH, Razzaq RA, Farooqui BJ. Multidrug-resistant typhoid fever in children: presentation and clinical features. Rev Infect Dis 1991; 13: 832–6.
   PubMedGoogle Scholar
• Gupta A. Multidrug-resistant typhoid fever in children: epidemiology and therapeutic approach. Pediatr Infect Dis J 1994; 13: 134–40.
   PubMed Web of Science ®Google Scholar
• Dar L, Gupta BL, Rattan A, Bhujwala RA, Shriniwas. Multidrug resistant Salmonella typhi in Delhi. Indian J Pediatr 1992; 59:221–4.
   PubMedGoogle Scholar
• Christ W, Lehnert T, Ulbrich B. Specific toxicologic aspects of the quinolones. Rev Infect Dis 1988; 10(1 Suppl):S141–6.
   PubMedGoogle Scholar
• Adam D. Use of quinolones in paediatric patients. Rev Infect Dis 1989; 11(5 Suppl):S1113–16.
   PubMedGoogle Scholar
• Naqvi SH, Bhutta ZA, Farooqui BJ. Therapy of multidrug resistant typhoid in 58 children. Scand J Infect Dis 1992; 24: 175–9.
   PubMed Web of Science ®Google Scholar
• Bauer AW, Kirby WMM, Sherris JC, Turck M. Antiobiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966; 45: 493–6.
   PubMed Web of Science ®Google Scholar
• Watersworth PM. Quantitative methods for bacterial sensitivity testing. In: Reeves DS, Phillips I, Williams JD, Wise R, eds. Laboratory Methods in Antimicrobial Chemotherapy. Edinburgh: Churchill Livingstone, 1984.
   Google Scholar
• Braddick MR, Crump BJ, Yee ML. How long should patients with Salmonella typhi or Salmonella paratyphi be followed up? A comparison of published guidelines. J Public Health Med 1991; 13: 101–7.
   PubMedGoogle Scholar
• Stuart BM, Pullen RL. Typhoid. Clinical analysis of three hundred and sixty cases. Arch Intern Med 1946; 78: 629–61.
   Google Scholar
• Pankey GA, Horton JM. Chloramphenicol. In: Ristucai AM, Cunha BA, eds. Antimicrobial Therapy. New York: Raven Press, 1984; 249–53.
   Google Scholar
• Rowe B, Threlfall EJ, Ward LR. Does chloramphenicol remain the drug of choice for typhoid? Epidemiol Infect 1987; 98: 379–89.
   PubMed Web of Science ®Google Scholar
• Mandal BK. Modern treatment of typhoid fever. J Infect 1991; 22: 1–4.
   PubMed Web of Science ®Google Scholar
• Bhutta ZA, Naqvi SH, Durrani S, Suria A. Chloramphenicol therapy of typhoid fever and its relationship to hepatic dysfunction. J Trop Pediatr 1991; 37: 320–2.
   PubMed Web of Science ®Google Scholar
• Feigin RD. Typhoid fever. In: Behrman RB, Vaughan VC, eds. Nelson's Textbook of Pediatrics, 13th edn. Philadelphia: WB Saunders, 1987; 603.
   Google Scholar
• Soe GB, Overturf GD. Treatment of typhoid fever and other systemic salmonellosis with cefotaxime, cefoperazone, and other newer cephalosporins. Rev Infect Dis 1987; 9: 719–36.
   PubMedGoogle Scholar
• McKendrick MW, Geddes AM, Wise R, Bax R. Cefotaxime in septicaemia including typhoid fever. J Antimicrob Chemother 1980; 6(Suppl A): 277–81.
   PubMed Web of Science ®Google Scholar
• Harish R, Sharma DB. Cefotaxime in multidrug resistant typhoid fever. Indian Pediatr 1994; 31: 193–6.
   PubMedGoogle Scholar
• Kuhn H, Angehrn P, Havas L. Autoradiographic evidence for penetration of 3H-ceftriaxone (Rociphene) into cells of spleen, liver and kidney of mice. Chemotherapy 1986; 32: 102–12.
   PubMed Web of Science ®Google Scholar
• Lassere R, Sangalang RP, Santiago L. Three-day treatment of typhoid fever with two different doses of ceftriaxone, compared to 14-day therapy with chloramphenicol: a randomized trial. J Antimicrob Chemother 1991; 28: 765–72.
   PubMed Web of Science ®Google Scholar
• Islam A, Butler T, Kabir I, Alam NH. Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial. Antimicrob Agents Chemother 1993; 37: 1572–5.
   PubMed Web of Science ®Google Scholar
• Smith MD, Duong NM, Hoa NTT, et al. Comparison of ofloxacin and ceftriaxone for short-course treatment of typhoid fever. Antimicrob Agents Chemother 1994; 38: 1716–20.
   PubMed Web of Science ®Google Scholar
• Acharya G, Butler T, Ho M, et al. Treatment of typhoid fever: randomized trial of a three-day course of ceftriaxone versus a fourteen day course of chloramphenicol. Am J Trop Med Hyg 1995; 52: 162–5.
   PubMed Web of Science ®Google Scholar
• Mishra S, Niranjan S, Kumar H, Sharma D. Ceftriaxone: use in multidrug resistant typhoid fever. Indian Pediatr 1993; 30: 67–70.
   PubMedGoogle Scholar
• Sethuraman S, Mahamood M, Kareem S. Furazolidone in multi-resistant childhood typhoid fever. Ann Trop Paediatr 1994; 14: 321–4.
   PubMed Web of Science ®Google Scholar
• Bhutta ZA, Khan IA, Molla AM. Therapy of multi- drug-resistant typhoid fever with oral Cefixime versus ceftriaxone. Pediatr Infect Dis J 1994; 13: 990–4.
   PubMed Web of Science ®Google Scholar
• Schaad UB. Use of quinolones in pediatrics. Drugs 1993; 45(Suppl 3): 37–41.
   PubMedGoogle Scholar
• Douidar SM, Snodgrass WR. Potential role of fluoroquinolones in pediatric infections. Rev Infect Dis 1989; 11: 878–89.
   PubMedGoogle Scholar
• Sen S, Goyal RS, Dev R. Ciprofloxacin in the management of multiple drug resistant typhoid fever. Indian Pediatr 1991; 28: 417–19.
   PubMedGoogle Scholar
• Bavedkar A, Chaudhari M, Bhave S, Pandit A. Ciprofloxacin in typhoid fever. Indian J Pediatr 1991; 58: 335–9.
   PubMedGoogle Scholar
• Dutta P, Rasaily R, Saha MR, et al. Ciprofloxacin in treatment of severe typhoid fever in children. Antimicrob Agents Chemother 1993; 37: 1197–9.
   PubMed Web of Science ®Google Scholar
• Biswal N’ Mathai B, Bhatia BD. P-floxacin induced arthropathy. Indian Pediatr 1993; 30: 718–19.
   PubMedGoogle Scholar
• Carmeli Y, Raz R, Schapiro JM, Alkan M. Typhoid fever in Ethiopian immigrants to Israel and native-born Israelis: A comparative study. Clin Infect Dis 1993; 16: 213–15.
   PubMed Web of Science ®Google Scholar
• Hoffman SL, Punjabi NH, Kumala S, et al. Reduction of mortality in chloramphenicol-treated severe typhoid fever by high dose dexamethasone. N Engl J Med 1984; 310: 82–8.
   PubMed Web of Science ®Google Scholar
• Punjabi NH, Hoffman SL, Edman DC, et al. Treatment of severe typhoid fever in children with high dose dexamethasone. Pediatr Infect Dis J 1988; 7: 598–600.
   PubMed Web of Science ®Google Scholar
• Rogerson SJ, Spooner VJ, Smith TA, Richens J. Hydrocortisone in chloramphenicol-treated severe typhoid fever in Papua New Guinea. Trans R Soc Trop Med Hyg 1991; 85: 113–16.
   PubMed Web of Science ®Google Scholar
• Butler T, Ho M, Acharya G, Tiwari M, Gallati H. Interleukin-6, gamma interferon, and tumor necrosis factor receptors in typhoid fever related to outcome of antimicrobial therapy. Antimicrob Agents Chemother 1993; 37: 2418–21.
   PubMed Web of Science ®Google Scholar
• Keuter M, Dharmana E, Gasem MH, et al. Patterns of proinflammatory cytokines and inhibitors during typhoid fever. J Infect Dis 1994; 169: 1306–11.
   PubMed Web of Science ®Google Scholar